Preclinical and in vitro studies examine GLP-3 (RT) in relation to simultaneous GLP-1, GIP and glucagon receptor signaling and hepatic lipid-oxidation pathways in experimental models.
Preclinical and in vitro studies examine GLP-3 (RT) in relation to simultaneous GLP-1, GIP and glucagon receptor signaling and hepatic lipid-oxidation pathways in experimental models.